Eli Lilly & Co. Stock Advances 14.3%, Outperforms Competitors

Dow Jones04-18

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Eli Lilly & Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23.

Eli Lilly & Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd.

The stock outperformed some of its competitors, as Johnson & Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99.

Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

April 17, 2025 16:33 ET (20:33 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2528991775?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-18 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2528991775","market":"hk","top_or_hot":-1,"title":"Eli Lilly & Co. Stock Advances 14.3%, Outperforms Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Eli Lilly &amp; Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23. \n</p>\n<p>\n     Eli Lilly &amp; Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99. \n</p>\n<p>\n     Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 17, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly & Co. Stock Advances 14.3%, Outperforms Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly & Co. Stock Advances 14.3%, Outperforms Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-18 04:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Eli Lilly &amp; Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23. \n</p>\n<p>\n     Eli Lilly &amp; Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99. \n</p>\n<p>\n     Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 17, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2528991775","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2528991775","pubTimestamp":1744921980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Eli Lilly & Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23.Eli Lilly & Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd.The stock outperformed some of its competitors, as Johnson & Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99.Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"礼来公司股价上涨14.3%，跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Eli Lilly & Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23. \n\n\n     Eli Lilly & Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd. \n\n\n     The stock outperformed some of its competitors, as Johnson & Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99. \n\n\n     Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 16:33 ET (20:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528991775","isCrawlerRequest":true}